GoodRx Holdings, Inc. - Common Stock (GDRX)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
120,458,255
Share change
-1,379,116
Total reported value
$599,884,035
Put/Call ratio
41%
Price per share
$4.98
Number of holders
176
Value change
-$4,664,411
Number of buys
86
Number of sells
87

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q2 2025

As of 30 Jun 2025, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 176 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 120,458,255 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, LAKEWOOD CAPITAL MANAGEMENT, LP, RENAISSANCE TECHNOLOGIES LLC, Silver Lake Group, L.L.C., Petrus Trust Company, LTA, DIMENSIONAL FUND ADVISORS LP, BlackRock, Inc., and Connor, Clark & Lunn Investment Management Ltd.. This page lists 176 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.